Ginger E Nicol1, Elizabeth J Campagna1, Lauren D Garfield1, John W Newcomer1, Joseph J Parks1, Elaine H Morrato1. 1. Dr. Nicol is with the Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri (e-mail: nicolg@wustl.edu ). Ms. Campagna and Dr. Morrato are with the Adult and Child Center for Health Outcomes Research and Delivery Science, University of Colorado Anschutz Medical Campus, Denver. Dr. Garfield is with Mercy Virtual Care Center, St. Louis. Dr. Newcomer is with the Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton. Dr. Parks is with MO HealthNet, Missouri Department of Social Services, Jefferson City, and with the Missouri Institute of Mental Health, University of Missouri-St. Louis.
Abstract
OBJECTIVE: This study compared metabolic screening among patients who received antipsychotic treatment at community mental health centers (CMHCs), with or without case management, and patients treated elsewhere. METHODS: Rates of glucose and lipid testing among youths and adults in Missouri Medicaid (N=9,473) who received antipsychotic treatment at CMHCs, with and without case management, were evaluated. Multivariable logistic regressions determined which characteristics were independently associated with metabolic testing. RESULTS: A total of 37.0% and 17.3% of youths and 68.7% and 34.9% of adults had glucose and lipid testing, respectively. Compared with treatment elsewhere, treatment at CMHCs, with or without case management, respectively, was associated with higher odds of glucose testing (youths, adjusted odds ratio [AOR]=1.68 and 1.89; adults, AOR=1.43 and 1.44) and lipid testing (youths, AOR=2.40 and 2.35; adults, AOR=1.97 and 1.48). CONCLUSIONS: CMHCs had higher rates of metabolic testing, possibly reflecting Missouri's efforts to promote testing in these settings.
OBJECTIVE: This study compared metabolic screening among patients who received antipsychotic treatment at community mental health centers (CMHCs), with or without case management, and patients treated elsewhere. METHODS: Rates of glucose and lipid testing among youths and adults in Missouri Medicaid (N=9,473) who received antipsychotic treatment at CMHCs, with and without case management, were evaluated. Multivariable logistic regressions determined which characteristics were independently associated with metabolic testing. RESULTS: A total of 37.0% and 17.3% of youths and 68.7% and 34.9% of adults had glucose and lipid testing, respectively. Compared with treatment elsewhere, treatment at CMHCs, with or without case management, respectively, was associated with higher odds of glucose testing (youths, adjusted odds ratio [AOR]=1.68 and 1.89; adults, AOR=1.43 and 1.44) and lipid testing (youths, AOR=2.40 and 2.35; adults, AOR=1.97 and 1.48). CONCLUSIONS: CMHCs had higher rates of metabolic testing, possibly reflecting Missouri's efforts to promote testing in these settings.
Authors: Ginger E Nicol; Elaine H Morrato; Mark C Johnson; Elizabeth Campagna; Michael D Yingling; Victor Pham; John W Newcomer Journal: Psychiatr Serv Date: 2011-01 Impact factor: 3.084
Authors: Elaine H Morrato; Benjamin G Druss; Daniel M Hartung; Robert J Valuck; Deborah Thomas; Richard Allen; Elizabeth Campagna; John W Newcomer Journal: Pharmacoepidemiol Drug Saf Date: 2010-11-15 Impact factor: 2.890
Authors: Elaine H Morrato; Ginger E Nicol; David Maahs; Benjamin G Druss; Daniel M Hartung; Robert J Valuck; Elizabeth Campagna; John W Newcomer Journal: Arch Pediatr Adolesc Med Date: 2010-04
Authors: Dan W Haupt; Lisa C Rosenblatt; Edward Kim; Ross A Baker; Richard Whitehead; John W Newcomer Journal: Am J Psychiatry Date: 2009-01-15 Impact factor: 18.112
Authors: Elaine H Morrato; Benjamin Druss; Daniel M Hartung; Robert J Valuck; Richard Allen; Elizabeth Campagna; John W Newcomer Journal: Arch Gen Psychiatry Date: 2010-01
Authors: Rita Haddad; Carolina Badke D'Andrea; Amanda Ricchio; Bradley Evanoff; Elaine H Morrato; Joseph Parks; John W Newcomer; Ginger E Nicol Journal: Front Digit Health Date: 2022-05-27
Authors: Andrew W Mulcahy; Sharon-Lise Normand; John W Newcomer; Benjamin Colaiaco; Julie M Donohue; Judith R Lave; Emmett Keeler; Mark J Sorbero; Marcela Horvitz-Lennon Journal: Psychiatr Serv Date: 2017-09-01 Impact factor: 3.084
Authors: Miriam C Tepper; Alexander M Cohen; Ana M Progovac; Andrea Ault-Brutus; H Stephen Leff; Brian Mullin; Carrie M Cunningham; Benjamin Lê Cook Journal: Psychiatr Serv Date: 2017-08-01 Impact factor: 3.084